TAG:
ehr
“July 19, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 10 – July 19, 2004 Issue
A transfusion of the wrong type of blood may have contributed to the death of a critically ill woman at Sarasota Memorial Hospital in Sarasota, Florida last month. The patient died about a day after the transfusion. Following the blood transfusion, a reaction had been observed. Atten…
Sysmex Anticipates Major Shifts In Laboratory Testing Market
By Robert Michel | From the Volume XI No. 9 – June 28, 2004 Issue
“Innovating from our core technologies will lead Sysmex into very different areas of laboratory testing.” —John Kershaw CEO SUMMARY: Sysmex America, Inc. surprised many this year when it hired its own sales and service team and begin distribu…
Eritrea Uses St. Louis For Reference Testing
By Robert Michel | From the Volume X No. 6 – May 5, 2003 Issue
CEO SUMMARY: On one level, it’s the classic story of volunteerism and help for a developing nation. But on another level, it’s a dramatic demonstration of how new technologies allow two hospital laboratories in St. Louis, Missouri to effectively provide reference laboratory tests and …
Major Changes at Dade Behring Soon to Be Visible In Lab Market
By Robert Michel | From the Volume IX No. 15 – October 28, 2002 Issue
Its recent financial restructuring now complete, Dade Behring prepares a “brand building” campaign CEO SUMMARY: Dade Behring is poised to become a tough and high-profile competitor in the laboratory diagnostics marketplace. Earlier this month,…
Non-Pathologists Altering U.S. Laboratory Industry
By Robert Michel | From the Volume IX No. 13 – September 16, 2002 Issue
CEO SUMMARY: It’s an interesting contradiction. On one hand, most pathologists enthusiastically recognize the value that diagnostic testing services provide to the healthcare community. On the other hand, too often it is non-laboratorians who provide the investment capital and entrepren…
Dade Behring Primed To Become Public Firm
By Robert Michel | From the Volume IX No. 11 – August 5, 2002 Issue
CEO SUMMARY: Dade Behring is executing an ambitious plan to restructure its finances and become a public company. To reduce its debt burden, Dade’s three owners are giving up their stock. Banks and bondholders will swap a portion of their debt for shares of stock in Dade. Once the finan…
Premier’s Lab Vendors Hooking Up Via Internet
By Robert Michel | From the Volume VII No. 17 – December 4, 2000 Issue
CEO SUMMARY: Laboratory members of Premier will soon be purchasing instruments, reagents, and supplies through medibuy.com’s Internet healthcare e-commerce site. Four major lab industry suppliers are actively working to link with the medibuy.com and Premier Web sites. For Premier, this …
“October 11, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 14 – October 11, 1999 Issue
Here’s a hats-off to Ortho-Clinical Diagnostics (OCD). At a time when everything in the healthcare system seems to be taking things away from clinical laboratories, OCD has organized a worthwhile laboratory management best practices day for its most loyal customers. Started four ye…
Diagnostics Companies React To Changing Lab Marketplace
By Robert Michel | From the Volume VI No. 7 – May 17, 1999 Issue
CEO SUMMARY: During the last five years, extensive consolidation among in vitro diagnostics (IVD) manufacturers has created a new class of industry giants. Their increased dominance of the IVD marketplace promises significant change to how laboratories acquire and use reagents, test kits,…
Bayer Acquires Chiron In Consolidation Move
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
CEO SUMMARY: As expected, consolidation within the diagnostics industry continues. This time it is Bayer, spending $1.1 billion to acquire Chiron’s diagnostics business. Once completed, Bayer will be the fourth-largest diagnostics company in the world. Laboratory customers of both firms…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized